Total Payments
$700.66
2024 Payments
$311.34
Companies
10
Transactions
25
Medicare Patients
2,833
Medicare Billing
$126,928
Payment Breakdown by Category
Food & Beverage$700.66 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $700.66 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $222.62 | 9 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $125.51 | 4 | $0 (2024) |
| Philips Electronics North America Corporation | $107.43 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $81.79 | 4 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $46.86 | 2 | $0 (2024) |
| Boston Scientific Corporation | $29.27 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $25.28 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.00 | 1 | $0 (2024) |
| Amgen Inc. | $21.85 | 1 | $0 (2024) |
| PFIZER INC. | $16.05 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $311.34 | 13 | Actelion Pharmaceuticals US, Inc. ($125.51) |
| 2023 | $293.99 | 5 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($127.29) |
| 2022 | $11.25 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($11.25) |
| 2020 | $39.14 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($39.14) |
| 2017 | $44.94 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($44.94) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Not Applicable | ||||||
| 07/30/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardiology | ||||||
| 07/29/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $42.79 | General |
| Category: Cardiology | ||||||
| 07/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: DIABETES | ||||||
| 07/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $40.54 | General |
| Category: Cardiology | ||||||
| 06/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Cardiology | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Cardiology | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/20/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Not Applicable | ||||||
| 09/27/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $113.80 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/20/2023 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: CDS - BG Mini_RM | ||||||
| 06/16/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $107.43 | General |
| Category: Medical Device | ||||||
| 03/09/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/27/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/01/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.25 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/15/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.45 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/22/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.59 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/06/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.10 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/15/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/22/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.20 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/15/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.24 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 303 | 370 | $80,885 | $23,528 |
| 2022 | 8 | 286 | 368 | $66,499 | $19,881 |
| 2021 | 8 | 795 | 961 | $96,721 | $31,267 |
| 2020 | 13 | 1,449 | 1,691 | $175,828 | $52,252 |
Total Patients
2,833
Total Services
3,390
Medicare Billing
$126,928
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 166 | $42,494 | $12,015 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $15,171 | $4,675 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 23 | 29 | $7,221 | $2,267 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 36 | $7,992 | $2,153 | 26.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $5,070 | $1,600 | 31.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 23 | $1,090 | $280.26 | 25.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 29 | 31 | $651.00 | $207.08 | 31.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 13 | 13 | $715.00 | $199.03 | 27.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 13 | 13 | $481.00 | $131.05 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 110 | $28,665 | $8,714 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 26 | 46 | $11,454 | $3,384 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 28 | 28 | $9,548 | $2,919 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $7,593 | $2,203 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 28 | $4,732 | $1,506 | 31.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2022 | 15 | 15 | $1,020 | $250.36 | 24.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 32 | 40 | $840.00 | $241.81 | 28.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 32 | 35 | $735.00 | $188.05 | 25.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 15 | 15 | $825.00 | $181.45 | 22.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 14 | $532.00 | $172.89 | 32.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 15 | 15 | $555.00 | $121.39 | 21.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 85 | 122 | $19,819 | $8,703 | 43.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 113 | 132 | $14,316 | $6,512 | 45.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 78 | 79 | $17,316 | $4,307 | 24.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $8,010 | $3,307 | 41.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 35 | $6,628 | $2,899 | 43.7% |
About Dr. Randolph Hutter, MD
Dr. Randolph Hutter, MD is a Cardiovascular Disease healthcare provider based in Ewa Beach, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1700047339.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randolph Hutter, MD has received a total of $700.66 in payments from pharmaceutical and medical device companies, with $311.34 received in 2024. These payments were reported across 25 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($700.66).
As a Medicare-enrolled provider, Hutter has provided services to 2,833 Medicare beneficiaries, totaling 3,390 services with total Medicare billing of $126,928. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Ewa Beach, HI
- Active Since 06/17/2008
- Last Updated 04/05/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1700047339
Products in Payments
- LifeVest (Device) $222.62
- (5044) MCOT (Device) $107.43
- OPSUMIT (Drug) $82.72
- LEQVIO (Drug) $64.61
- Arcalyst (Drug) $46.86
- UPTRAVI (Drug) $42.79
- BodyGuardian (Device) $29.27
- FARXIGA (Drug) $25.28
- JARDIANCE (Drug) $24.00
- Repatha (Biological) $21.85
- ENTRESTO (Drug) $17.18
- VYNDAQEL (Drug) $16.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.